Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis

L Bernabela, B Bermas - Current Rheumatology Reports, 2025 - Springer
Abstract Purpose of this Review Immune checkpoint inhibitors (ICI) have revolutionized
cancer therapy over the past decade. Unfortunately, immune related adverse events (irAEs) …

Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?

LC Cappelli - Seminars in Arthritis and Rheumatism, 2024 - Elsevier
Immune checkpoint molecules like PD-1 and its ligand PD-L1 and CTLA-4 are important
regulators of the immune system. Medications blocking these pathways, immune checkpoint …

[HTML][HTML] Use of Upadacitinib to Treat a Severe Flare-Up of Rheumatoid Arthritis During Anti-PD-1 Immune Checkpoint Inhibitor Therapy for Stage IV Squamous Cell …

S Mori, K Nakamura, M Shimamura, K Ohe - Journal of Clinical Medicine, 2024 - mdpi.com
Background: Immune checkpoint inhibitor (ICI) therapy is becoming the standard of care for
the treatment of advanced non-small-cell lung cancer. However, T-cell activation by ICIs …

Las drogas Inhibidoras de los Puntos de Control Inmunológico para tratamiento del cáncer. Un Nuevo reto para la Onco-Reumatología de Cuba

GAR Llerena - Revista Cubana de Reumatología, 2024 - revreumatologia.sld.cu
En los últimos años se ha ido desarrollando una nueva disciplina médica denominada
Onco-Reumatología. Está considerada un punto de unión entre la Oncología y la …

Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events …

JA Sparks - Rheumatic Disease Clinics, 2024 - rheumatic.theclinics.com
Over the last decade, immune checkpoint inhibitors (ICIs) have revolutionized the treatment
of cancer. 1 ICIs are indicated across a growing list of cancer types and are now being used …